Martino Bardelli
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.
Journal: Nature communications
Published: June 20, 2025
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.
Journal: Vaccine
Published: March 01, 2024
Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein.
Journal: Malaria journal
Published: July 10, 2023
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.
Journal: Frontiers in immunology
Published: March 24, 2023
Naturally-acquired and Vaccine-induced Human Monoclonal Antibodies to Plasmodium vivax Duffy Binding Protein Inhibit Invasion of Plasmodium knowlesi (PvDBPOR) Transgenic Parasites.
Journal: bioRxiv : the preprint server for biology
Published: March 22, 2023
Building Blocks of Virtuous Science Communication: Grant Funding, Policy Making, and Public Engagement.
Journal: DNA and cell biology
Published: December 23, 2021
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors.
Journal: Cell reports. Medicine
Published: August 19, 2020
A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage Infection.
Journal: iScience
Published: February 06, 2020
Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease.
Journal: Brain : a journal of neurology
Published: February 15, 2019
Last Updated: 09/26/2026